Showing results (11-20 of 656) with videos related to

Sort By:
Pageof 66
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
The Lancet. Microbe|April 10, 2025
Evaluating the performance of common reference laboratory tests for acute dengue diagnosis: a systematic review and meta-analysis of RT-PCR, NS1 ELISA, and IgM ELISAKamla Pillay, Suzanne H Keddie, Elizabeth Fitchett, et al.
The Lancet. Microbe|April 7, 2025
Temporal and geographical lineage dynamics of invasive Streptococcus pyogenes in Australia from 2011 to 2023: a retrospective, multicentre, clinical and genomic epidemiology studyOuli Xie, Rebecca H Chisholm, Leo Featherstone, et al.
The Lancet. Microbe|June 14, 2025
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre studyTaryn A Eubank, Jinhee Jo, M Jahangir Alam, et al.
The Lancet. Microbe|June 14, 2025
Universal versus targeted chlorhexidine and mupirocin decolonisation and clinical and molecular epidemiology of Staphylococcus epidermidis bloodstream infections in patients in intensive care in Scotland, UK: a controlled time-series and longitudinal genotypic studySara Sharaf, Timothy Lawes, Deon Roos, et al.
The Lancet. Microbe|May 27, 2025
Whole-genome sequencing, strain composition, and predicted antimicrobial resistance of Streptococcus pneumoniae causing invasive disease in England in 2017-20: a prospective national surveillance studyJoshua C D'Aeth, Marta Bertran, Fariyo Abdullahi, et al.
The Lancet. Microbe|May 19, 2025
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaChama Chanda, Freddie Kibengo, Michael Mutua, et al.
The Lancet. Microbe|May 24, 2025
Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling studyBenjamin J Singer, Mireille Gomes, Jean T Coulibaly, et al.
The Lancet. Microbe|May 11, 2022
Clinical relevance and plasmid dynamics of mcr-1-positive Escherichia coli in China: a multicentre case-control and molecular epidemiological studyYan Jiang, Ying Zhang, Jun Lu, et al.
The Lancet. Microbe|May 11, 2022
Epidemiological and molecular investigations of a point-source outbreak of Dracunculus medinensis infecting humans and dogs in Chad: a cross-sectional studySarah Anne J Guagliardo, Elizabeth Thiele, Karmen Unterwegner, et al.
Pageof 66